| Name | Title | Contact Details |
|---|
Georgia Pediatric Pulmonology Associates is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Regenstrief Institute, Inc., an international leader in electronic medical records and health care data integration, is a medical research and development organization focused on improving quality of care, efficiency of health care delivery, and enhancing patient outcomes.
Synvasive Technology Inc is a El Dorado Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
At Vireo Systems we develop, manufacture and market products and brands that enhance the health of humans and animals. Our company is dedicated to maintaining excellence in all production processes and protecting the environment while delivering safe, ...